Skip to main content

Table 3 Multivariable linear regression models for significant predictors of phylloquinone, %ucOC and PIVKA-II

From: Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease

 

β Coefficient

95% Confidence interval

p

Phylloquinone (R2 = 0.275, n = 42)

   

 Triglycerides

0.54

0.25 to 0.84

0.001

 Total cholesterol

-0.036

-0.46 to 0.39

0.87

%ucOC (R2 = 0.14, n = 41)

   

 Phosphate

14.80

1.71 to 29.13

0.028

 PTH

-0.14

-0.26 to -0.02

0.028

 Coronary artery disease

-9.14

-18.73 to 0.46

0.061

PIVKA-II (R2 = 0.16, n = 43)

   

 Age, years

0.05

0.01 to 0.10

0.033

 Coronary artery disease

1.40

-0.14 to 2.93

0.07

  1. PTH, parathyroid hormone; %ucOC, percentage of uncarboyxlated osteocalcin; PIVKA-II, proteins induced by vitamin K absence or antagonism.